Matches in SemOpenAlex for { <https://semopenalex.org/work/W2032704623> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W2032704623 endingPage "S715" @default.
- W2032704623 startingPage "S715" @default.
- W2032704623 abstract "Purpose/Objective(s)Standard esophagogram criteria are unreliable for staging esophageal carcinoma therapy; however, change of tumor shape can identify patients who have achieved a clinical response. In the current study the authors prospectively compared survival between patients classified as responders and those classified as nonresponders by esophagogram.Materials/MethodsThe shape of the tumor in esophagogram was check before and after neoadjuvant therapy in patients who were candidates for multimodality treatment. Response was defined as no visible carcinoma in esophagogram with barium.ResultsOf 229 patients with thoracic esophageal squamous cell carcinoma, all patients underwent preoperative RT . The median age was 56 years, and most patients were male (76.4%). Operations performed included Ivor-Lewis (60.3%), transhiatal (3.1%), three-hole (35.8%), or left thoracoabdominal (0.9%) esophagectomy. Perioperative mortality rate was 4.8%. Median overall survival (OS) of the entire group was 24 months, and the 5-year and 10-year OS rate was 30% and 21%.Overall, patients with responders had a median survival and 5-year,10-year survival of 41.4 months, 49%, 33.1% compared with 19.2 months,26.6%, 18.9% for non-responders (p = 0.024). Patients with pathologic completely response (pCR) had an improved OS and disease-free survival (DFS) compared with those patients who were not pCR (p = 0.003 and p < 0.0005, respectively). Esophagogram with barium cannot predict patient's pathologic response who underwent preoperative radiotherapy.ConclusionsPatients with esophageal carcinoma who respond to neoadjuvant treatment as identified by Esophagogram with barium in tumor shape have a significantly better prognosis than nonresponders. Purpose/Objective(s)Standard esophagogram criteria are unreliable for staging esophageal carcinoma therapy; however, change of tumor shape can identify patients who have achieved a clinical response. In the current study the authors prospectively compared survival between patients classified as responders and those classified as nonresponders by esophagogram. Standard esophagogram criteria are unreliable for staging esophageal carcinoma therapy; however, change of tumor shape can identify patients who have achieved a clinical response. In the current study the authors prospectively compared survival between patients classified as responders and those classified as nonresponders by esophagogram. Materials/MethodsThe shape of the tumor in esophagogram was check before and after neoadjuvant therapy in patients who were candidates for multimodality treatment. Response was defined as no visible carcinoma in esophagogram with barium. The shape of the tumor in esophagogram was check before and after neoadjuvant therapy in patients who were candidates for multimodality treatment. Response was defined as no visible carcinoma in esophagogram with barium. ResultsOf 229 patients with thoracic esophageal squamous cell carcinoma, all patients underwent preoperative RT . The median age was 56 years, and most patients were male (76.4%). Operations performed included Ivor-Lewis (60.3%), transhiatal (3.1%), three-hole (35.8%), or left thoracoabdominal (0.9%) esophagectomy. Perioperative mortality rate was 4.8%. Median overall survival (OS) of the entire group was 24 months, and the 5-year and 10-year OS rate was 30% and 21%.Overall, patients with responders had a median survival and 5-year,10-year survival of 41.4 months, 49%, 33.1% compared with 19.2 months,26.6%, 18.9% for non-responders (p = 0.024). Patients with pathologic completely response (pCR) had an improved OS and disease-free survival (DFS) compared with those patients who were not pCR (p = 0.003 and p < 0.0005, respectively). Esophagogram with barium cannot predict patient's pathologic response who underwent preoperative radiotherapy. Of 229 patients with thoracic esophageal squamous cell carcinoma, all patients underwent preoperative RT . The median age was 56 years, and most patients were male (76.4%). Operations performed included Ivor-Lewis (60.3%), transhiatal (3.1%), three-hole (35.8%), or left thoracoabdominal (0.9%) esophagectomy. Perioperative mortality rate was 4.8%. Median overall survival (OS) of the entire group was 24 months, and the 5-year and 10-year OS rate was 30% and 21%.Overall, patients with responders had a median survival and 5-year,10-year survival of 41.4 months, 49%, 33.1% compared with 19.2 months,26.6%, 18.9% for non-responders (p = 0.024). Patients with pathologic completely response (pCR) had an improved OS and disease-free survival (DFS) compared with those patients who were not pCR (p = 0.003 and p < 0.0005, respectively). Esophagogram with barium cannot predict patient's pathologic response who underwent preoperative radiotherapy. ConclusionsPatients with esophageal carcinoma who respond to neoadjuvant treatment as identified by Esophagogram with barium in tumor shape have a significantly better prognosis than nonresponders. Patients with esophageal carcinoma who respond to neoadjuvant treatment as identified by Esophagogram with barium in tumor shape have a significantly better prognosis than nonresponders." @default.
- W2032704623 created "2016-06-24" @default.
- W2032704623 creator A5015312536 @default.
- W2032704623 creator A5029283948 @default.
- W2032704623 creator A5041641072 @default.
- W2032704623 creator A5055421411 @default.
- W2032704623 creator A5063263317 @default.
- W2032704623 date "2010-11-01" @default.
- W2032704623 modified "2023-10-12" @default.
- W2032704623 title "Esophagogram with Barium Assessment of Multimodality Therapy Predicts Survival of Esophageal Squamous Cell Carcinoma Patients" @default.
- W2032704623 doi "https://doi.org/10.1016/j.ijrobp.2010.07.1657" @default.
- W2032704623 hasPublicationYear "2010" @default.
- W2032704623 type Work @default.
- W2032704623 sameAs 2032704623 @default.
- W2032704623 citedByCount "0" @default.
- W2032704623 crossrefType "journal-article" @default.
- W2032704623 hasAuthorship W2032704623A5015312536 @default.
- W2032704623 hasAuthorship W2032704623A5029283948 @default.
- W2032704623 hasAuthorship W2032704623A5041641072 @default.
- W2032704623 hasAuthorship W2032704623A5055421411 @default.
- W2032704623 hasAuthorship W2032704623A5063263317 @default.
- W2032704623 hasBestOaLocation W20327046231 @default.
- W2032704623 hasConcept C121608353 @default.
- W2032704623 hasConcept C126322002 @default.
- W2032704623 hasConcept C126838900 @default.
- W2032704623 hasConcept C141071460 @default.
- W2032704623 hasConcept C2777297899 @default.
- W2032704623 hasConcept C2777546739 @default.
- W2032704623 hasConcept C2778292576 @default.
- W2032704623 hasConcept C2779742542 @default.
- W2032704623 hasConcept C2994415158 @default.
- W2032704623 hasConcept C31174226 @default.
- W2032704623 hasConcept C509974204 @default.
- W2032704623 hasConcept C530470458 @default.
- W2032704623 hasConcept C71924100 @default.
- W2032704623 hasConcept C90924648 @default.
- W2032704623 hasConceptScore W2032704623C121608353 @default.
- W2032704623 hasConceptScore W2032704623C126322002 @default.
- W2032704623 hasConceptScore W2032704623C126838900 @default.
- W2032704623 hasConceptScore W2032704623C141071460 @default.
- W2032704623 hasConceptScore W2032704623C2777297899 @default.
- W2032704623 hasConceptScore W2032704623C2777546739 @default.
- W2032704623 hasConceptScore W2032704623C2778292576 @default.
- W2032704623 hasConceptScore W2032704623C2779742542 @default.
- W2032704623 hasConceptScore W2032704623C2994415158 @default.
- W2032704623 hasConceptScore W2032704623C31174226 @default.
- W2032704623 hasConceptScore W2032704623C509974204 @default.
- W2032704623 hasConceptScore W2032704623C530470458 @default.
- W2032704623 hasConceptScore W2032704623C71924100 @default.
- W2032704623 hasConceptScore W2032704623C90924648 @default.
- W2032704623 hasIssue "3" @default.
- W2032704623 hasLocation W20327046231 @default.
- W2032704623 hasOpenAccess W2032704623 @default.
- W2032704623 hasPrimaryLocation W20327046231 @default.
- W2032704623 hasRelatedWork W2081558191 @default.
- W2032704623 hasRelatedWork W2155310726 @default.
- W2032704623 hasRelatedWork W2239503473 @default.
- W2032704623 hasRelatedWork W2334671410 @default.
- W2032704623 hasRelatedWork W2508356849 @default.
- W2032704623 hasRelatedWork W2738510732 @default.
- W2032704623 hasRelatedWork W2743130678 @default.
- W2032704623 hasRelatedWork W4306252415 @default.
- W2032704623 hasRelatedWork W810470455 @default.
- W2032704623 hasRelatedWork W2096456165 @default.
- W2032704623 hasVolume "78" @default.
- W2032704623 isParatext "false" @default.
- W2032704623 isRetracted "false" @default.
- W2032704623 magId "2032704623" @default.
- W2032704623 workType "article" @default.